PMID: 1522753
Aimed at people who are severely overweight, Wegovy's active ingredient is a medicine called semaglutide, which helps control blood sugar, lowers appetite, and makes patients feel fuller
Safety profiles for once-weekly Ozempic (semaglutide) injection and once-daily Ozempic pill (semaglutide) injection and once-daily Ozempic pill Safety and tolerability evaluated across clinical trials Rates of GI symptoms across placebo-controlled trials with Ozempic injection and semaglutide tablets 1,2,a The most common adverse reactions reported in 5% of patients taking Ozempic injection and Ozempic tablets are nausea, vomiting, diarrhea, abdominal pain, and constipation
If alternating, each cycle should last a minimum of 3 months, with 6 months being preferable
Adverse Events From Semaglutide GLP-1s are on the verge of remaking CKD